Key facts
- It has raised $2.9M.
- Notable investors include CDP Venture Capital (Rome), LIFTT, Bioindustry Park Silvano Fumero, CNR-NANO, Deep Ocean Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for INTA (italy)
- ·The full record, as it builds
Funding rounds
No funding rounds for INTA (italy) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About INTA (italy)
Developer of a disposable cartridge technology designed to detect biological analytes such as proteins, viruses and bacteria in body fluids. The company's technology can identify bio-analytes on a small chip with precision through advanced immobilization techniques of probe molecules on the surface of biosensors and through data analysis based on artificial intelligence-based algorithms, enabling patients to receive diagnoses without unnecessary analysis.
- Sector
- Healthcare
- HQ
- Pisa, Italy
- Founded
- 2020
- Employees
- 12
- Website
- inta-dx.com/
- Ownership
- Privately Held (backing)
INTA (italy) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in INTA (italy) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on INTA (italy) in its N-PORT filings yet. We sweep new filings monthly.